Company details, activities, locations, contacts, financials and reviews for Enteris BioPharma.
Main company details for Enteris BioPharma.
Enteris BioPharma offers innovative formulation solutions built around its proprietary oral drug delivery technology platform – Peptelligence®. Since its founding in 2013, Enteris BioPharma has advanced into the clinic multiple internal and external programs leveraging its Peptelligence® platform. The technology has been developed and proven effective to enable the delivery of BSC III and IV compounds including peptides, peptidomimetics, and small molecules with low oral bioavailability. In addition to its formulation development expertise, Enteris BioPharma has a 32,000 square-foot GMP facility in Boonton, New Jersey, offering a range of manufacturing services. Enteris BioPharma operates as an independent, wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH). SWK offers Enteris with sound financial backing and long range planning support.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Enteris BioPharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.